← Kiniksa Pharmaceuticals International, plc
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | — | $45.6m | $72.0m | $46.9m | $114.0m | $122.5m | $122.7m | $108.0m | $183.6m | $165.6m | |
| Prepaid Expense and Other Assets, Current | — | $1.4m | $6.4m | $8.2m | $9.6m | $6.6m | $10.5m | $17.5m | $20.1m | $42.6m | |
| Cash, Cash Equivalents, and Short-term Investments | — | — | $307.3m | $233.4m | $323.5m | $182.2m | $190.6m | $206.4m | $243.6m | $414.1m | |
| Short-term Investments | — | — | $235.3m | $186.5m | $209.4m | $59.7m | $67.9m | $98.4m | $60.0m | $248.5m | |
| Cash and cash equivalents | $18k | $45.6m | $72.0m | $46.9m | $114.0m | $122.5m | $122.7m | $108.0m | $183.6m | $165.6m | |
| Accounts receivable, net | — | — | — | — | — | $4.0m | $12.7m | $21.3m | $41.7m | $15.6m | |
| Prepaid expenses and other current assets | — | $1.4m | $6.4m | $8.2m | $9.6m | $6.6m | $10.5m | $17.5m | $20.1m | $42.6m | |
| Inventory, Net | — | — | — | — | — | $3.7m | $21.6m | $31.1m | $26.4m | $54.9m | |
| Assets, Current | — | $47.1m | $313.8m | $241.6m | $333.2m | $196.4m | $243.1m | $276.3m | $331.8m | $527.2m | |
| Total current assets | $22k | $47.1m | $313.8m | $241.6m | $333.2m | $196.4m | $243.1m | $276.3m | $331.8m | $527.2m | |
| Property, Plant and Equipment, Net | — | $125k | $6.4m | $6.4m | $4.1m | $2.8m | $1.7m | $734k | $662k | $1.9m | |
| Intangible asset, net | — | — | — | — | — | $19.2m | $18.2m | $17.2m | $16.2m | $15.2m | |
| Intangible Assets | $0 | — | — | — | — | — | — | — | — | — | |
| Operating Lease, Right-of-Use Asset | — | — | — | $1.9m | $6.6m | $5.5m | $5.4m | $11.9m | $10.4m | $9.8m | |
| Other Assets, Noncurrent | — | — | — | — | $5.6m | $8.7m | $5.8m | $827k | $10.3m | $11.3m | |
| Operating lease right-of-use assets | — | — | — | $1.9m | $6.6m | $5.5m | $5.4m | $11.9m | $10.4m | $9.8m | |
| Other long-term assets | — | — | — | — | $5.6m | $8.7m | $5.8m | $827k | $10.3m | $11.3m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | — | — | — | — | — | $4.0m | $12.7m | $21.3m | $41.7m | $15.6m | |
| Deferred tax assets | — | $238k | $1.2m | $4.4m | $10k | — | $185.5m | $219.3m | $211.2m | $198.1m | |
| Operating lease liabilities | — | — | — | $1.7m | $2.1m | $3.4m | $3.3m | $2.3m | $2.0m | $3.0m | |
| Other current liabilities | $28k | — | $218k | $25k | $37k | $1.5m | $5.8m | $8.2m | $16.1m | $22.1m | |
| Non-current operating lease liabilities | — | — | — | $955k | $4.9m | $2.7m | $2.6m | $10.0m | $7.9m | $6.5m | |
| Ordinary shares value | — | $1k | $13k | $15k | $18k | $18k | $19k | $20k | $20k | $21k | |
| Accrued Liabilities, Current | — | $6.2m | $16.4m | $20.4m | $29.2m | $38.0m | $30.1m | $44.7m | $32.4m | $42.0m | |
| Total shareholders' equity | ($679k) | ($89.7m) | $279.3m | $225.4m | $311.9m | $185.0m | $396.1m | $438.8m | $438.4m | $567.6m | |
| Assets | — | $47.5m | $322.0m | $254.5m | $349.5m | $232.8m | $459.7m | $526.3m | $580.6m | $763.6m | |
| Total assets | $22k | $47.5m | $322.0m | $254.5m | $349.5m | $232.8m | $459.7m | $526.3m | $580.6m | $763.6m | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $1.7m | $2.1m | $3.4m | $3.3m | $2.3m | $2.0m | $3.0m | |
| Accounts Payable, Current | $568k | $1.2m | $10.9m | $5.7m | $503k | $1.9m | $7.9m | $8.2m | $2.0m | $2.0m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $955k | $4.9m | $2.7m | $2.6m | $10.0m | $7.9m | $6.5m | |
| Accrued collaboration expenses | — | — | — | — | — | — | — | $16.9m | $48.2m | $70.0m | |
| Non-current deferred revenue | — | — | — | — | — | — | $12.0m | $12.0m | $31.8m | $31.8m | |
| Liabilities, Current | — | $17.4m | $42.6m | $27.8m | $31.8m | $44.8m | $47.1m | $63.7m | $100.6m | $139.2m | |
| Total current liabilities | $701k | $17.4m | $42.6m | $27.8m | $31.8m | $44.8m | $47.1m | $63.7m | $100.6m | $139.2m | |
| Other Liabilities, Noncurrent | — | — | — | $326k | $805k | $270k | $1.8m | $1.9m | $1.8m | $18.5m | |
| Other long-term liabilities | — | — | $144k | $326k | $805k | $270k | $1.8m | $1.9m | $1.8m | $18.5m | |
| Long-Term Debt | $100k | — | — | — | — | — | — | — | — | — | |
| Liabilities | — | $17.4m | $42.7m | $29.1m | $37.5m | $47.8m | $63.5m | $87.5m | $142.1m | $196.0m | |
| Total liabilities | $701k | $17.4m | $42.7m | $29.1m | $37.5m | $47.8m | $63.5m | $87.5m | $142.1m | $196.0m | |
| Stockholders’ equity: | |||||||||||
| Additional Paid in Capital | $1.5m | $1.3m | $473.5m | $581.5m | $829.4m | $860.5m | $888.1m | $916.8m | $959.7m | $1.0b | |
| Retained Earnings (Accumulated Deficit) | — | ($91.0m) | ($194.2m) | ($356.1m) | ($517.5m) | ($675.4m) | ($492.0m) | ($477.9m) | ($521.1m) | ($462.1m) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | — | — | ($4k) | $33k | ($34k) | ($66k) | $44k | $6k | ($163k) | ($25k) | |
| Accumulated other comprehensive loss | — | — | ($4k) | $33k | ($34k) | ($66k) | $44k | $6k | ($163k) | ($25k) | |
| Accumulated deficit | ($2.2m) | ($91.0m) | ($194.2m) | ($356.1m) | ($517.5m) | ($675.4m) | ($492.0m) | ($477.9m) | ($521.1m) | ($462.1m) | |
| Stockholders' Equity Attributable to Parent | — | ($89.7m) | $279.3m | $225.4m | $311.9m | $185.0m | $396.1m | $438.8m | $438.4m | $567.6m | |
| Liabilities and Equity | — | $47.5m | $322.0m | $254.5m | $349.5m | $232.8m | $459.7m | $526.3m | $580.6m | $763.6m | |
| Total liabilities and shareholders' equity | $22k | $47.5m | $322.0m | $254.5m | $349.5m | $232.8m | $459.7m | $526.3m | $580.6m | $763.6m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.